ciprofloxacin has been researched along with Respiratory Tract Diseases in 6 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Respiratory Tract Diseases: Diseases involving the RESPIRATORY SYSTEM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of pancreatic enzyme supplementation on the absorption of an oral dose of 250 mg of ciprofloxacin was studied in six patients with cystic fibrosis in a crossover design." | 7.68 | Effects of enzyme supplementation on oral absorption of ciprofloxacin in patients with cystic fibrosis. ( Buchanan, N; Cooper, PJ; Mack, G, 1991) |
| "The effect of pancreatic enzyme supplementation on the absorption of an oral dose of 250 mg of ciprofloxacin was studied in six patients with cystic fibrosis in a crossover design." | 3.68 | Effects of enzyme supplementation on oral absorption of ciprofloxacin in patients with cystic fibrosis. ( Buchanan, N; Cooper, PJ; Mack, G, 1991) |
| " An oral dose of 500 mg every 12 h was administered and both the clinical response and the pharmacokinetic profile were investigated." | 1.27 | Ciprofloxacin: multiple-dose pharmacokinetic and clinical results in patients with hypercrinic bronchopulmonary diseases. ( Braga, PC; Cortelazzi, R; Cosentina, R; Fraschini, F; Odero, A; Salvini, P; Scaglione, F; Scarpazza, G; Trazzi, R, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fernández-Barat, L | 1 |
| Vázquez Burgos, N | 1 |
| Alcaraz, V | 1 |
| Bueno-Freire, L | 1 |
| López-Aladid, R | 1 |
| Cabrera, R | 1 |
| Gabarrús, A | 1 |
| Palomeque, A | 1 |
| Oscanoa, P | 1 |
| Ceccato, A | 1 |
| Motos, A | 1 |
| Amaro, R | 1 |
| Bernardi, T | 1 |
| Provot, C | 1 |
| Soler-Comas, A | 1 |
| Muñoz, L | 1 |
| Vila, J | 1 |
| Torres, A | 1 |
| Ivanov, DV | 1 |
| Budanov, SV | 1 |
| Oliphant, CM | 1 |
| Green, GM | 1 |
| Kikuchi, N | 1 |
| Kawashima, T | 1 |
| Yamagishi, F | 1 |
| Suzuki, K | 1 |
| Yasuda, J | 1 |
| Niijima, Y | 1 |
| Mizutani, F | 1 |
| Tabeta, H | 1 |
| Mack, G | 1 |
| Cooper, PJ | 1 |
| Buchanan, N | 1 |
| Fraschini, F | 1 |
| Braga, PC | 1 |
| Cosentina, R | 1 |
| Salvini, P | 1 |
| Cortelazzi, R | 1 |
| Scarpazza, G | 1 |
| Scaglione, F | 1 |
| Trazzi, R | 1 |
| Odero, A | 1 |
2 reviews available for ciprofloxacin and Respiratory Tract Diseases
| Article | Year |
|---|---|
[Ciprofloxacin and antibacterial therapy of respiratory tract infections].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Humans; Resp | 2006 |
Quinolones: a comprehensive review.
Topics: Ciprofloxacin; Drug Interactions; Humans; Male; Prostatitis; Quinolones; Respiratory Tract Diseases; | 2002 |
1 trial available for ciprofloxacin and Respiratory Tract Diseases
| Article | Year |
|---|---|
[Clinical evaluation of ciprofloxacin in pulmonary infections in the patients with chronic respiratory diseases].
Topics: Adult; Aged; Chronic Disease; Ciprofloxacin; Female; Humans; Male; Middle Aged; Pneumonia; Respirato | 1991 |
3 other studies available for ciprofloxacin and Respiratory Tract Diseases
| Article | Year |
|---|---|
The value of biofilm testing to guide antimicrobial stewardship in chronic respiratory diseases.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Biofilms; Ciprofloxacin; Humans; Phenotype; Pseudo | 2023 |
Effects of enzyme supplementation on oral absorption of ciprofloxacin in patients with cystic fibrosis.
Topics: Administration, Oral; Adolescent; Adult; Ciprofloxacin; Cystic Fibrosis; Female; Humans; Intestinal | 1991 |
Ciprofloxacin: multiple-dose pharmacokinetic and clinical results in patients with hypercrinic bronchopulmonary diseases.
Topics: Adult; Aged; Bronchitis; Chronic Disease; Ciprofloxacin; Humans; Kinetics; Lung; Male; Middle Aged; | 1987 |